Ranjit Bindra on Navigating Dynamics with Parents in Pediatric Oncology

Video

Dr. Ranji Bindra explains the delicate balance that must go into treating the parents of patients in pediatric oncology.

Ranjit Bindra, MD, PhD, from Smilow Cancer Hospital at Yale explains the importance of communicating honestly and sensitively with parents when treating pediatric patients.

In pediatric oncology, nurses have to treat both the patient and the family. This requires a delicate balance that allows the parents to be hopeful and engaged, but realistic. Bindra highlights the importance of revising communication in relation to the patient's status.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
2 experts are featured in this series.
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
2 experts are featured in this series.
Image of a woman with shoulder-length black hair wearing headphones and a white sweater
Related Content
physical activity

Targeted Interventions for Physical Activity Aids Long-Term Effects in AYAs With Cancer

Ariana Pelosci
April 12th 2025
Article

Findings highlighted that increased physical activity was associated with a variety of benefits in improving overall well-being in early adolescent and young adult survivors.

The Vitals

Jacki Garcia and Kristin Hendrickson on Navigating Patients Through Phase 0 Trials

Lindsay Fischer
July 15th 2023
Podcast

Jacki Garcia, RN, BSN, CNRN; and Kristin Hendrickson, BA, RN, discuss phase 0 trials and how they can help expedite the research process for brain cancer therapies.

Illustration of a person looking upset, with their head on their knees

Intro to AYA Patients, Survivors, and Substance Use

Christina Monaco, LMSW
February 5th 2025
Article

Adolescent and young adult survivors of cancer face increased substance use risks due to developmental delays, limited support, and coping mechanisms, necessitating targeted prevention.

Oncology Nursing News

A Look Back at 2022 FDA Approvals in Oncology

Oncology Nursing News
January 2nd 2023
Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

image of brain representing central nervous system

Larotrectinib Is Promising for Pediatric TRK Fusion-Positive CNS Tumors

Ryan Scott
November 26th 2024
Article

Larotrectinib led to rapid/durable responses and high disease control rates in children with TRK fusion-position central nervous system cancers.

Mirdametinib Boosts Outcomes, QOL in NF1-PN

Mirdametinib Boosts Outcomes, QOL in NF1-PN

Russ Conroy
November 17th 2024
Article

Mirdametinib led to confirmed responses and meaningful pain and health-related quality of life improvements in both children and adults with neurofibromatosis type 1-associated PNs.